MetaCap

Maze Therapeutics Statistics

NASDAQ: MAZEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

31.37-1.06 (-3.27%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Maze Therapeutics by the numbers

Maze Therapeutics has a market capitalization of $1.72 billion based on 54.68M shares outstanding. With trailing EPS of $-2.62, Maze Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 6.8% above its 50-day average and 1.1% above its 200-day average.

Average daily trading volume is 737.14K shares, or about $23.1 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

MAZE valuation vs. peer median

MAZE compared with the median of 8 peer companies
MetricMAZEPeer medianDifference
Market cap$1.72B$1.64B+4%
Avg. volume737.14K1.79M-59%

Peer median across 8 companies: LYCA, REPL, COAG, BCRX, VIR, RXRX, ALVO, WWB.

Valuation

Price and trading

Previous close
32.43
Open
31.77
Day range
30.88 – 32.80
52-week range
21.95 – 53.65
52-week change
-13.49%
Beta
—
Volume
818.93K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
1.72B
Forward Pe
-9.51
Eps
-2.62
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
53.65
Week52 Low
21.95
Avg Volume
737.14K
Shares Outstanding
54.68M
Ma50
29.39
Ma200
31.02
Earnings Date
Nov 9, 2026
Pct From52w High
-41.53%
Pct From52w Low
42.92%

Related